Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter Study Comparing Taxotere Plus Curcumin Versus Taxotere Plus Placebo Combination in First-line Treatment of Prostate Cancer Metastatic Castration Resistant (CURTAXEL)

NCT02095717 is registered in ClinicalTrials.gov with Centre Jean Perrin as lead sponsor.

NCT NCT02095717
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02095717 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter Study Comparing Taxotere Plus Curcumin Versus Taxotere Plus Placebo Combination in First-line Treatment of Prostate Cancer Metastatic Castration Resistant (CURTAXEL)
Lead sponsor
Centre Jean Perrin
Phase
Phase 2
Overall status
Terminated
Start date
March 31, 2014
Completion date
April 30, 2018
Enrollment
50 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer metastatic castration resistant